USSTOCK.TODAY
Weekend. Closed
Log in Sign up

Cumberland Pharmaceuticals shares fall 11% in after-hours trading following clinical results

Investing.com +1 ·

CPIX
CPIX Cumberland Pharmaceuticals Inc
$8.49 +0.12%
View chart & analysis →
  1. 1Cumberland Pharmaceuticals Inc shares fell 11% in after-hours trading on Friday.
  2. 2The 12-month clinical trial enrolled 41 patients.
  3. 3Cumberland Pharmaceuticals Inc plans to submit the clinical study report to the FDA.

So what's the key point?

Cumberland Pharmaceuticals shares dropped 11% after the market closed. This happened after the company released results from a trial involving 41 patients.

Source Investing.com +1 · View original ↗

Related 3-line summaries

Wells Fargo Appoints Sole CEO for Consumer Financial Services and Strengthens AI Role Banking Dive +1 · 2h agoProcter & Gamble raises price target following Q1 results exceeding expectations Stocktwits +2 · 2h agoAT&T shares fall 8% amid concerns over SpaceX entering wireless market The Motley Fool +1 · 2h ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news